Studies were assessed on four criteria:
the studies had to have used American Psychiatric Association DSM-III criteria for panic disorder with or without agoraphobia or agoraphobia with panic attacks, or DSM-III-R criteria for panic disorder with or without agoraphobia;
the studies had to provide well-described treatments that were administered in as standard a manner as possible, with therapists adequately skilled in the administration of treatment;
the experimental treatment (which can be a combined-modality treatment) was the sole treatment being administered during the study period; and
during the follow-up interval, it had to be indicated whether additional treatments for panic were being used by the patients.
If an intervening treatment was sought out or required by patients during the follow-up interval, this information needed to be closely tracked, as it contains important implications about the long-term efficacy of the experimental treatment. [A:By two authors independently, with consensus by discussion].